تداخلات مينوسيكلين

Avoid concomitant use of isotretinoin and EMROSI because isotretinoin, a systemic retinoid, is also known to cause idiopathic intracranial hypertension. (نشرة مينوسيكلين، التحذيرات والاحتياطات)

Avoid concomitant use of isotretinoin and EMROSI because isotretinoin, a systemic retinoid, is also known to cause idiopathic intracranial hypertension. (نشرة مينوسيكلين، التحذيرات والاحتياطات)

Penicillin Because bacteriostatic drugs may interfere with the bactericidal action of penicillin, avoid giving EMROSI in conjunction with penicillin. (نشرة مينوسيكلين، التداخلات الدوائية)

Penicillin Because bacteriostatic drugs may interfere with the bactericidal action of penicillin, avoid giving EMROSI in conjunction with penicillin. (نشرة مينوسيكلين، التداخلات الدوائية)

Penicillin Because bacteriostatic drugs may interfere with the bactericidal action of penicillin, avoid giving EMROSI in conjunction with penicillin. (نشرة مينوسيكلين، التداخلات الدوائية)

Penicillin Because bacteriostatic drugs may interfere with the bactericidal action of penicillin, avoid giving EMROSI in conjunction with penicillin. (نشرة مينوسيكلين، التداخلات الدوائية)

Penicillin Because bacteriostatic drugs may interfere with the bactericidal action of penicillin, avoid giving EMROSI in conjunction with penicillin. (نشرة مينوسيكلين، التداخلات الدوائية)

Avoid concomitant use of isotretinoin and EMROSI because isotretinoin, a systemic retinoid, is also known to cause idiopathic intracranial hypertension. (نشرة مينوسيكلين، التحذيرات والاحتياطات)

Penicillin Because bacteriostatic drugs may interfere with the bactericidal action of penicillin, avoid giving EMROSI in conjunction with penicillin. (نشرة مينوسيكلين، التداخلات الدوائية)

Penicillin Because bacteriostatic drugs may interfere with the bactericidal action of penicillin, avoid giving EMROSI in conjunction with penicillin. (نشرة مينوسيكلين، التداخلات الدوائية)

Penicillin Because bacteriostatic drugs may interfere with the bactericidal action of penicillin, avoid giving EMROSI in conjunction with penicillin. (نشرة مينوسيكلين، التداخلات الدوائية)

Avoid concomitant use of isotretinoin and EMROSI because isotretinoin, a systemic retinoid, is also known to cause idiopathic intracranial hypertension. (نشرة مينوسيكلين، التحذيرات والاحتياطات)

EMROSI is contraindicated in patients with a history of hypersensitivity to any of the tetracyclines [see Warnings and Precautions (5.1) ]. (نشرة مينوسيكلين، موانع الاستعمال)

EMROSI is contraindicated in patients with a history of hypersensitivity to any of the tetracyclines [see Warnings and Precautions (5.1) ]. (نشرة مينوسيكلين، موانع الاستعمال)

Avoid concomitant use of isotretinoin and EMROSI because isotretinoin, a systemic retinoid, is also known to cause idiopathic intracranial hypertension. (نشرة مينوسيكلين، التحذيرات والاحتياطات)

Penicillin Because bacteriostatic drugs may interfere with the bactericidal action of penicillin, avoid giving EMROSI in conjunction with penicillin. (نشرة مينوسيكلين، التداخلات الدوائية)

Penicillin Because bacteriostatic drugs may interfere with the bactericidal action of penicillin, avoid giving EMROSI in conjunction with penicillin. (نشرة مينوسيكلين، التداخلات الدوائية)

Patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (نشرة مينوسيكلين، التداخلات الدوائية)

• Concomitant administration of tetracycline reduces atovaquone concentrations; use caution when coadministering. (نشرة أتوفاكون، التداخلات الدوائية)

• Tetracycline may reduce atovaquone concentrations; parasitemia should be closely monitored. (نشرة أتوفاكون وبروغوانيل، التداخلات الدوائية)

Patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (نشرة مينوسيكلين، التداخلات الدوائية)

Calcium acetate capsules may decrease the bioavailability of tetracyclines or fluoroquinolones via this mechanism. (نشرة أسيتات الكالسيوم، التداخلات الدوائية)

الحديد يرتبط بهذه الأدوية في الأمعاء ويقلّل امتصاصها؛ افصل بين الجرعات. (NIH Office of Dietary Supplements, Iron)

الزنك يقلّل امتصاص المضادات الحيوية من الكينولونات والتتراسيكلينات؛ تناول المضاد الحيوي قبل الزنك بساعتين على الأقل أو بعده بأربع إلى ست ساعات. (NIH Office of Dietary Supplements, Zinc)

الكالسيوم يرتبط بهذه الأدوية في الأمعاء وقد يقلّص بشدة الكمية الممتصة منها؛ افصل بين الجرعات. (NIH Office of Dietary Supplements, Calcium)

المكملات ومضادات الحموضة المحتوية على المغنيسيوم تقلّل امتصاص هذه الأدوية؛ افصل بين الجرعات بساعتين على الأقل. (NIH Office of Dietary Supplements, Magnesium)

Patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (نشرة مينوسيكلين، التداخلات الدوائية)

Patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (نشرة مينوسيكلين، التداخلات الدوائية)

Patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (نشرة مينوسيكلين، التداخلات الدوائية)

…antagonists, fibrates, propoxyphene, pentoxifylline, somatostatin analogs, anabolic steroids and androgens, cyclophosphamide, phenyramidol, guanethidine, fluconazole, sulfinpyrazone, tetracyclines, clarithromycin, disopyramide, quinolones, and those drugs that are highly protein-bound, such as fluoxetine, nonsteroidal anti-inflammatory drugs, salicylates, sulfonamides,… (نشرة بيوغليتازون وغليميبيريد، التداخلات الدوائية)

Patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (نشرة مينوسيكلين، التداخلات الدوائية)

Antibiotics Drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as Rocuronium Bromide Injection include certain antibiotics (e.g., aminoglycosides; vancomycin; tetracyclines; bacitracin; polymyxins; colistin; and sodium colistimethate). (نشرة روكورونيوم، التداخلات الدوائية)

Patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (نشرة مينوسيكلين، التداخلات الدوائية)

Drug Interactions Some studies have shown that simultaneous sucralfate administration in healthy volunteers reduced the extent of absorption (bioavailability) of single doses of the following: cimetidine, digoxin, fluoroquinolone antibiotics, ketoconazole, l-thyroxine, phenytoin, quinidine, ranitidine, tetracycline, and theophylline. (نشرة سوكرالفات، التداخلات الدوائية)

…antagonists, fibrates, propoxyphene, pentoxifylline, somatostatin analogs, anabolic steroids and androgens, cyclophosphamide, phenyramidol, guanethidine, fluconazole, sulfinpyrazone, tetracyclines, clarithromycin, disopyramide, quinolones, and those drugs that are highly protein-bound, such as fluoxetine, nonsteroidal anti-inflammatory drugs, salicylates, sulfonamides,… (نشرة غليميبيريد، التداخلات الدوائية)

Patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (نشرة مينوسيكلين، التداخلات الدوائية)

Drug Interactions Cholestyramine for Oral Suspension USP may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic), or propranolol (basic), as well as tetracycline, penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis. (نشرة كوليسترامين، التداخلات الدوائية)

The absorption of tetracycline, furosemide, penicillin G, hydrochlorothiazide, and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride; these drugs were not tested to determine the effect of administration one hour before colestipol hydrochloride. (نشرة كوليستيبول، التداخلات الدوائية)

Tetracycline and other drugs that interact with magnesium Simultaneous administration of tetracycline with quinapril hydrochloride reduced the absorption of tetracycline by approximately 28% to 37%, possibly due to the high magnesium content in quinapril tablets. (نشرة كينابريل، التداخلات الدوائية)

Although tetracycline may be concomitantly administered with quinine sulfate, patients should be monitored closely for adverse reactions associated with quinine sulfate. (نشرة كينين، التداخلات الدوائية)

Examples of relevant classes of compounds where antacids have been demonstrated to reduce bioavailability include antibiotics (such as quinolones, ampicillin, and tetracyclines), thyroid hormones, ACE inhibitors, statin lipid regulators, and anti-malarials. (نشرة لانثانوم، التداخلات الدوائية)

Caution should be exercised when JUXTAPID is used with other medications known to have potential for hepatotoxicity, such as isotretinoin, amiodarone, acetaminophen (>4 g/day for ≥3 days/week), methotrexate, tetracyclines, and tamoxifen. (نشرة لوميتابيد، التحذيرات والاحتياطات)

Patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (نشرة مينوسيكلين، التداخلات الدوائية)

Patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (نشرة مينوسيكلين، التداخلات الدوائية)

Antacids and Iron Preparations Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium and iron-containing preparations. (نشرة مينوسيكلين، التداخلات الدوائية)

A similar association, though less marked, has been suggested for barbiturates, phenylbutazone, phenytoin sodium, and possibly with griseofulvin, ampicillin, and tetracyclines. (نشرة إيثينوديول ثنائي الأسيتات وإيثينيل إستراديول، التداخلات الدوائية)

EMROSI may induce hyperpigmentation in many organs, including nails, bone, skin, eyes, thyroid, visceral tissue, oral cavity (teeth, mucosa, alveolar bone), sclerae and heart valves. (نشرة مينوسيكلين، التحذيرات والاحتياطات)

Antacids and Iron Preparations Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium and iron-containing preparations. (نشرة مينوسيكلين، التداخلات الدوائية)

EMROSI may induce hyperpigmentation in many organs, including nails, bone, skin, eyes, thyroid, visceral tissue, oral cavity (teeth, mucosa, alveolar bone), sclerae and heart valves. (نشرة مينوسيكلين، التحذيرات والاحتياطات)

Antacids and Iron Preparations Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium and iron-containing preparations. (نشرة مينوسيكلين، التداخلات الدوائية)

Antacids and Iron Preparations Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium and iron-containing preparations. (نشرة مينوسيكلين، التداخلات الدوائية)

WARNINGS DEMECLOCYCLINE HYDROCHLORIDE, LIKE OTHER TETRACYCLINE-CLASS ANTIBIOTICS, CAN CAUSE FETAL HARM WHEN ADMINISTERED TO A PREGNANT WOMAN. (نشرة ديميكلوسيكلين، التحذيرات)

Antacids and Iron Preparations Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium and iron-containing preparations. (نشرة مينوسيكلين، التداخلات الدوائية)

The following antibiotics have been associated with various degrees of paralysis: aminoglycosides (such as neomycin, streptomycin, kanamycin, gentamicin, and dihydrostreptomycin); tetracyclines; bacitracin; polymyxin B; colistin; and sodium colistimethate. (نشرة فيكورونيوم، الاحتياطات)

EMROSI may induce hyperpigmentation in many organs, including nails, bone, skin, eyes, thyroid, visceral tissue, oral cavity (teeth, mucosa, alveolar bone), sclerae and heart valves. (نشرة مينوسيكلين، التحذيرات والاحتياطات)

EMROSI may induce hyperpigmentation in many organs, including nails, bone, skin, eyes, thyroid, visceral tissue, oral cavity (teeth, mucosa, alveolar bone), sclerae and heart valves. (نشرة مينوسيكلين، التحذيرات والاحتياطات)

EMROSI may induce hyperpigmentation in many organs, including nails, bone, skin, eyes, thyroid, visceral tissue, oral cavity (teeth, mucosa, alveolar bone), sclerae and heart valves. (نشرة مينوسيكلين، التحذيرات والاحتياطات)

Antacids and Iron Preparations Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium and iron-containing preparations. (نشرة مينوسيكلين، التداخلات الدوائية)

EMROSI may induce hyperpigmentation in many organs, including nails, bone, skin, eyes, thyroid, visceral tissue, oral cavity (teeth, mucosa, alveolar bone), sclerae and heart valves. (نشرة مينوسيكلين، التحذيرات والاحتياطات)

…omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinical use are immunoassays which are specific… (نشرة أمينوفيلين، التداخلات الدوائية)

…ranitidine famotidine rifabutin felodipine roxithromycin finasteride Sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin * Refer to PRECAUTIONS , Drug Interactions for information regarding table. (نشرة ثيوفيلين، التداخلات الدوائية)

…additional doses of Cisatracurium Besylate Injection, and to determine whether adjustments need to be made to the dose with subsequent administration. † Examples: aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, sodium colistimethate Drug or Drug Class Clinical Implications * Succinylcholine The use of succinylcholine… (نشرة سيساتراكوريوم، التداخلات الدوائية)